Aquestive Therapeutics Inc (AQST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
Sales | 11,134 | 10,682 | 11,463 | 13,265 | 12,270 |
Cost of Goods | 4,737 | 5,305 | 4,625 | 5,242 | 4,214 |
Gross Profit | 6,397 | 5,377 | 6,838 | 8,023 | 8,056 |
Operating Expenses | 11,739 | 16,395 | 16,316 | 21,027 | 18,008 |
Operating Income | -4,605 | -10,713 | -8,853 | -12,762 | -9,738 |
Interest Expense | 1,487 | 1,704 | 3,688 | 3,572 | 3,479 |
Other Income | 14,160 | 65 | 5 | 32 | -3 |
Pre-tax Income | 8,068 | -12,352 | -12,536 | -16,302 | -13,220 |
Net Income Continuous | 8,068 | -12,352 | -12,536 | -16,302 | -13,220 |
Net Income | $8,068 | $-12,352 | $-12,536 | $-16,302 | $-13,220 |
EPS Basic Total Ops | 0.15 | -0.21 | -0.23 | -0.36 | -0.32 |
EPS Basic Continuous Ops | 0.15 | -0.20 | -0.23 | -0.36 | -0.32 |
EPS Diluted Total Ops | 0.11 | -0.21 | -0.23 | -0.36 | -0.32 |
EPS Diluted Continuous Ops | 0.11 | -0.20 | -0.23 | -0.36 | -0.32 |
EPS Diluted Before Non-Recurring Items | 0.11 | -0.23 | -0.23 | N/A | N/A |
EBITDA(a) | $-4,224 | $-10,258 | $-8,209 | $-12,026 | $-8,971 |